Laboratory data (mean ± SE) | Living liver donor (n = 5) | Without chemotherapy (n = 9) | With chemotherapy (n = 8) | p value* |
---|---|---|---|---|
T-Bill (mg/dl) | ||||
Preoperative | 0.69 ± 0.05 | 0.77 ± 0.18 | 0.45 ± 0.04 | 0.03 |
5 postoperative days | 1.64 ± 0.44 | 1.42 ± 0.27 | 1.28 ± 0.27 | 0.81 |
Early period | 0.93 ± 0.20 | 0.80 ± 0.21 | 1.60 ± 1.02 | 0.61 |
Late period | 0.79 ± 0.11 | 0.72 ± 0.08 | 0.74 ± 0.08 | 0.97 |
PT-INR | ||||
Preoperative | 0.97 ± 0.02 | 0.96 ± 0.02 | 0.97 ± 0.03 | 0.82 |
5 postoperative days | 1.11 ± 0.03 | 1.12 ± 0.03 | 1.10 ± 0.04 | 0.81 |
Early period | 1.07 ± 0.05 | 1.01 ± 0.03 | 1.05 ± 0.04 | 0.68 |
Late period | 0.95 ± 0.01 | 0.94 ± 0.03 | 1.02 ± 0.03 | 0.19 |
Plt ( × 10 3 μl) | ||||
Preoperative | 25.7 ± 1.6 | 22.5 ± 1.3 | 25.3 ± 1.9 | 0.35 |
5 postoperative days | 19.7 ± 1.4 | 16.8 ± 1.3 | 16.8 ± 2.0 | 0.4 |
Early period | 25.7 ± 1.9 | 16.8 ± 1.3 | 26.6 ± 3.7 | 0.16 |
Late period | 22.1 ± 0.9 | 20.2 ± 2.9 | 19.4 ± 2.2 | 0.1 |
Alb (g/Dl) | ||||
Preoperative | 4.3 ± 0.1 | 4.0 ± 0.2 | 3.9 ± 0.2 | 0.22 |
5 postoperative days | 3.1 ± 0.1 | 3.1 ± 0.1 | 2.9 ± 0.1 | 0.55 |
Early period | 3.6 ± 0.2 | 3.5 ± 0.2 | 3.5 ± 0.2 | 0.74 |
Late period | 4.2 ± 0.1 | 3.9 ± 0.2 | 3.4 ± 0.3 | 0.003 |